Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth
Aditya Birla Sun Life Mutual Fund
NAV
₹36.6800
as of 17 Nov 2026
Expense Ratio
2.27%
AUM
₹1,076 Cr
Lumpsum returns (CAGR)
- 1Y
- +16.48%
- 3Y
- +18.33%
- 5Y
- +14.31%
- Since Inception
- +19.32%
SIP returns (XIRR)
- 1Y
- +23.05%
- 3Y
- +14.54%
- 5Y
- +17.78%
- Since Inception
- +17.62%
What history actually did — last 7 years (Nov 2019 – Nov 2026)
A ₹5,000 monthly SIP for the last 7 years (Nov 2019 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹7,67,204 today — ₹4,20,000 invested, 17.2% XIRR.
₹4,20,000
Invested
₹7,67,204
Value today
17.2%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 7 years (Nov 2019 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 7 years ago would be ₹3,55,834 today (19.9% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2019 would still hold ₹27,91,137.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹7,67,204 in this fund vs ₹6,72,174 in the benchmark — outperformance of ₹95,030.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 7 years (Nov 2019 – Nov 2026) (22 Mar 2020) would be ₹3,97,629 today (3.98×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.71
Sharpe Ratio
+0.10
Alpha
0.57
Beta
0.71
Sortino
11.90%
Std Dev
-9.73%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology76.39%
- Healthcare Services21.73%
- Insurance0.71%
- Chemicals & Petrochemicals0.58%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Torrent Pharmaceuticals Ltd.8.83%
- 2Sun Pharmaceutical Industries Ltd.8.35%
- 3Cipla Ltd.7.10%
- 4Apollo Hospitals Enterprise Ltd.6.60%
- 5Sai Life Sciences Ltd.4.54%
- 6Aurobindo Pharma Ltd.4.50%
- 7Ajanta Pharma Ltd.4.17%
- 8Dr. Lal Path Labs Ltd.3.90%
- 9Mankind Pharma Ltd.3.56%
- 10Emcure Pharmaceuticals Ltd.3.06%
Investment objective — in the AMC’s words
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
About This Fund
Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Aditya Birla Sun Life Mutual Fund. The fund has been operational for over 7 years. It manages assets worth ₹1,076 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare. The current expense ratio is 2.27%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations